I have owned this stock since 2015 and have recouped my investment several times over. Bought in a large stake at $3.04. This company is the real deal and their drug has been working for years. To question results is one thing, to attack ones character is just wrong. I have watched the CEO lead this company through stormy waters but we are heading to smooth sailing